Taking people in ChinaNo phase
Registry Following People with Parkinson's Disease and LRRK2 Gene Variants
Builds a database of Chinese patients with Parkinson's disease and LRRK2 gene variants.
Plain-language title generated from the registry record
Registry title: Chinese PD-LRRK2 Registry
Key facts
- Where
- Changsha, ChinaSee the site
Where in China
- Xiangya Hospital of Central South UniversityChangsha, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xiangya Hospital of Central South University
- Trial code
- NCT03523104
- Record updated
- 29 May 2018
- Original description
The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.Read full original descriptionShow less
The Chinese Parkinson's Disease With LRRK2 Variants Registry
The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.
Inclusion: Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with positive LRRK2 variants.
Exclusion: -.